Gene · 4036
Papers3,623
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,623
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection. | Nat Commun | 2023 | 37468466 | PubTator, text mining | PubMed |
| Non-invasive estimation of split renal function from routine 68Ga-SSR-PET/CT scans. | Front Med (Lausanne) | 2023 | 37448797 | PubTator, text mining | PubMed |
Identification and Characterization of the Very-Low-Density Lipoprotein Receptor Gene from Branchiostoma belcheri: Insights into the Origin and Evolution of the Low-Density Lipoprotein Receptor Gene Family. | Animals (Basel) | 2023 | 37443991 | PubTator, text mining | PubMed |
| Intrinsic mechanism and pharmacologic treatments of noise-induced hearing loss. | Theranostics | 2023 | 37441605 | PubTator, text mining | PubMed |
| Gene Expression of Clusterin, Tissue Inhibitor of Metalloproteinase-1, and Their Receptors in Retinal Pigment Epithelial Cells and Müller Glial Cells Is Modulated by Inflammatory Stresses. | Adv Exp Med Biol | 2023 | 37440036 | PubTator, text mining | PubMed |
| Association between urinary C-megalin levels and progressive kidney dysfunction: a cohort study based on the diabetes distress and care registry at Tenri (DDCRT 24). | Acta Diabetol | 2023 | 37439857 | PubTator, text mining | PubMed |
| Natural history and variability in albuminuria in pediatric and murine sickle cell anemia. | Blood Adv | 2023 | 37428862 | PubTator, text mining | PubMed |
Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis. | Front Immunol | 2023 | 37426643 | PubTator, text mining | PubMed |
| Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells. | PeerJ | 2023 | 37426416 | PubTator, text mining | PubMed |
| Minimal change disease with papillary thyroid carcinoma: a report of two adult cases. | BMC Nephrol | 2023 | 37407942 | PubTator, text mining | PubMed |
| Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome. | Kidney Int | 2023 | 37406929 | PubTator, text mining | PubMed |
| An efficient selenium transport pathway of selenoprotein P utilizing a high-affinity ApoER2 receptor variant and being independent of selenocysteine lyase. | J Biol Chem | 2023 | 37406814 | PubTator, text mining | PubMed |
| AI-Assisted Ultrasound for the Early Diagnosis of Antibody-Negative Autoimmune Thyroiditis. | J Multidiscip Healthc | 2023 | 37404960 | PubTator, text mining | PubMed |
| Therapeutic strategies to recover ependymal barrier after inflammatory damage: relevance for recovering neurogenesis during development. | Front Neurosci | 2023 | 37397456 | PubTator, text mining | PubMed |
| The pathological potential of ependymal cells in mild traumatic brain injury. | Front Cell Neurosci | 2023 | 37396927 | PubTator, text mining | PubMed |
| The selenoprotein P-LRP5/6-WNT3A complex promotes tumorigenesis in sporadic colorectal cancer. | J Clin Invest | 2023 | 37395277 | PubTator, text mining | PubMed |
| Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. | Cancer Med | 2023 | 37387515 | PubTator, text mining | PubMed |
| Protein Biomarkers in Chronic Kidney Disease in Children-What Do We Know So Far? | J Clin Med | 2023 | 37373629 | PubTator, text mining | PubMed |
| Biological and Catalytic Properties of Selenoproteins. | Int J Mol Sci | 2023 | 37373256 | PubTator, text mining | PubMed |
| Clarifying the Heterogeneity in Response to Vitamin D in the Development, Prevention, and Treatment of Type 2 Diabetes Mellitus: A Narrative Review. | Int J Environ Res Public Health | 2023 | 37372772 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4036/papers?page=18